Professor
ENT and Allergy Associates
New York, NY, United States
Ofer Jacobowitz MD PhD FAASM is an internationally recognized expert in obstructive sleep apnea and rhinology. He is the co-director of sleep at ENT and Allergy Associates, the largest ENT group in the USA and is a clinical professor at Northwell/Hofstra University. He has been a researcher in hypoglossal neurostimulation for over a decade. He conducts research on OSA, nasal obstruction and consults for new technologies. He is a co-director of a sleep surgery international fellowship.
Dr Jacobowitz is a fellow and chair of the Sleep Committee of the American Academy of Otolaryngology Head and Neck Surgery. He served as secretary, chair of the sleep-disordered breathing guidelines committee and as a member of the governing council of the World Sleep Society. He is a fellow of the American Academy of Sleep medicine and past chair of the sleep-related breathing disorders section.
He is a founding member of the International Surgical Sleep Society and co-chaired the 2019 meeting. He regularly presents in academic venues around the world, authored many peer-reviewed journal articles, book chapters and is the chief editor for the 2026 Elsevier textbook “Sleep Apnea and Snoring”.
He is a graduate of MIT and the Mount Sinai School of Medicine’s MD PhD, Medical Scientist training program. He enjoys seeing his friends around the world, learning languages and photography.
Saturday, October 17, 2026
1:00 PM - 2:00 PM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
What's New in 2026? AAO-HNSF Position Statement Updates for Adult and Pediatric Sleep Surgery
Sunday, October 18, 2026
11:00 AM - 11:50 AM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.
Snoring and OSA Treatments in 2026 from GLP-1 Agonists to Surgery
Monday, October 19, 2026
9:30 AM - 10:30 AM PT
Disclosure(s):
faculty for this accredited education activity has no relationship(s) with ineligible companies to disclose.